Viewing Study NCT05523661


Ignite Creation Date: 2025-12-24 @ 12:09 PM
Ignite Modification Date: 2026-01-10 @ 10:17 PM
Study NCT ID: NCT05523661
Status: UNKNOWN
Last Update Posted: 2023-11-28
First Post: 2021-11-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Dasatinib Plus Anti-CD19/CD22 Bispecific CAR-T Cell Therapy for Elderly Ph-positive ALL Patients
Sponsor:
Organization: